Autosomal recessive calculator: carrier probability, the 25% rule, and consanguinity
A working guide to calculating autosomal recessive risk from a pedigree: carrier-by-carrier matings, Bayesian updating after unaffected siblings, population carrier frequencies, and the effect of consanguinity.
Examples include cystic fibrosis, sickle cell disease, spinal muscular atrophy, Tay-Sachs disease, and phenylketonuria. Written for genetic counsellors and clinical geneticists doing day-to-day carrier screening and reproductive risk assessment.
Short version. In autosomal recessive (AR) inheritance, two copies of the disease allele are needed to manifest the phenotype. Carriers (heterozygotes) are typically unaffected. When two carriers have a child, each pregnancy has a 25% probability of being affected, a 50% probability of being a carrier, and a 25% probability of being a non-carrier. When one member of a couple has a known carrier status and the other does not, the partner's prior carrier probability is drawn from population data and the couple risk is calculated as the product of per-parent carrier probabilities multiplied by the 25% transmission from a carrier-carrier cross. Consanguinity amplifies recessive risk by increasing the probability that both parents share an ancestral allele; this is quantified by Wright's inbreeding coefficient F.
What "autosomal recessive" means
An autosomal recessive condition is caused by mutations on both copies of an autosomal gene. Heterozygotes (carriers) carry one mutant and one wild-type allele and are typically unaffected because the wild-type allele provides sufficient protein function. Homozygotes or compound heterozygotes have two non-functional or reduced-function alleles and manifest the phenotype.
The canonical AR family has two unaffected carrier parents. Each parent produces gametes that are 50% mutant and 50% wild-type. The cross of two such gametes yields the classic Punnett square: 25% affected (AA), 50% carrier (Aa), and 25% non-carrier (aa), where A is the mutant allele by convention for this discussion. Because carriers are unaffected, AR conditions often appear to "skip" generations, manifesting only when two carriers happen to partner.
Pedigree features that suggest a recessive pattern
Look for these features on the pedigree:
- Affected siblings with unaffected parents: the single most characteristic pattern.
- Both sexes affected in similar numbers, since the gene is autosomal.
- Horizontal pattern within a sibship rather than vertical transmission across generations.
- No male-to-male transmission restriction: fathers can transmit to sons, distinguishing from X-linked.
- Consanguinity in the family: uncle-niece, first-cousin, or more distant unions increase prior probability of AR disease and should trigger careful pedigree review.
- Specific ancestry: several AR conditions have elevated allele frequency in particular populations (cystic fibrosis in Northern Europeans, sickle cell in sub-Saharan African and Mediterranean populations, Tay-Sachs and several others in Ashkenazi Jewish populations).
The core calculation: carrier by carrier
For a couple both confirmed as carriers (for example, both tested as CFTR F508del heterozygotes), each pregnancy has:
- 1/4 probability of an affected child (homozygous or compound heterozygous)
- 2/4 probability of a carrier child (heterozygous, unaffected)
- 1/4 probability of a non-carrier child
This 25/50/25 ratio holds independently for each pregnancy. Three unaffected children do not change the per-pregnancy risk for a fourth, although observing three unaffected children will update the posterior carrier probability of a given unaffected child through Bayesian conditioning.
Specifically, if an offspring is known to be unaffected, the 1/4 affected outcome is ruled out, and the remaining probabilities re-normalise to 2/3 carrier and 1/3 non-carrier. This is a classic application of Bayes' theorem and is the basis for sibling carrier counselling: the unaffected sibling of an affected individual with two carrier parents has a 2/3 prior probability of being a carrier themselves before any testing.
When only one parent's carrier status is known
The more common scenario is that one partner has a family history (a known affected relative) while the other does not. The couple risk then depends on the prior probability that each partner is a carrier, multiplied by the 1/4 transmission conditional on both being carriers.
For the partner with family history, the prior carrier probability comes from pedigree analysis. An unaffected sibling of an affected individual (both parents being carriers) has a 2/3 prior carrier probability. The uncle or aunt of an affected individual has a 1/2 prior carrier probability (each of the affected individual's parents is a carrier; each of their siblings has a 1/2 chance of having inherited the carrier allele from the shared grandparent who is an obligate carrier, conditional on only one grandparent being the carrier). A first cousin once removed is 1/4, and so on.
For the partner with no family history, the prior carrier probability comes from population carrier frequency data. Hardy-Weinberg equilibrium gives q2 = disease incidence, 2pq ≈ carrier frequency for rare alleles. If cystic fibrosis has an incidence of roughly 1 in 2,500 in Northern Europeans, the carrier frequency is approximately 1 in 25. Note that carrier frequencies vary by ancestry and by gene; consult current population data for the specific condition.
The couple risk is then: P(partner A is carrier) × P(partner B is carrier) × 1/4. For a 2/3 × 1/25 × 1/4 example, this is approximately 1 in 150 per pregnancy.
Consanguinity as a risk amplifier
Consanguinity — partnership between related individuals — increases the probability that both partners share a rare recessive allele inherited from a common ancestor. The coefficient of inbreeding F measures the probability that the two alleles at a locus in the offspring are identical by descent from a recent common ancestor. For first cousins, F is approximately 1/16; for second cousins, F is approximately 1/64; for uncle-niece or double first cousins, F is higher. See our consanguinity calculator guide for the detailed relationships.
For a rare recessive condition with allele frequency q, the risk of affected offspring is approximately Fq + (1-F)q2. For very small q, the Fq term dominates: consanguinity substantially increases recessive disease risk for rare alleles, while the absolute risk remains modest for common alleles. This asymmetry explains why consanguinity counselling emphasises family-specific recessive risks and cascade testing rather than a single generic risk figure.
Consanguinity also increases the prior probability of pseudodominance: an affected proband partnering a carrier cousin can appear to transmit vertically.
Worked clinical examples
| Condition | Population with elevated carrier frequency | Counselling note |
|---|---|---|
| Cystic fibrosis (CFTR) | Northern European | Carrier screening is routine in reproductive genetics; many pathogenic variants on panel. |
| Sickle cell disease (HBB) | Sub-Saharan African, Mediterranean, Middle Eastern, South Asian | Newborn screening in many settings; heterozygotes have sickle cell trait. |
| Spinal muscular atrophy (SMN1) | Pan-ethnic | Carrier screening increasingly offered pre-conceptually; SMN2 modifies severity. |
| Tay-Sachs disease (HEXA) | Ashkenazi Jewish, French Canadian, Cajun | Classic target of ancestry-based carrier screening. |
| Phenylketonuria (PAH) | Variable across Europe and the Middle East | Identified via newborn screening; dietary treatment highly effective. |
In each of these, the core calculation is the same: identify each partner's carrier probability, multiply, and apply the 1/4 transmission term. What differs is the population from which the carrier frequency is drawn, the sensitivity of the available carrier screening assay, and the residual risk after a negative test.
Pseudodominance and other pitfalls
Pseudodominance arises when an affected homozygote partners with an unrelated carrier. The offspring of such a union have a 50% probability of being affected, mimicking an autosomal dominant pattern. The condition remains recessive at the gene level; only the phenotype pattern looks dominant. Pseudodominance is most likely with high-frequency alleles (for example haemochromatosis in Northern Europeans) and in consanguineous families where carrier frequency within the kinship is elevated.
Other traps to watch for:
- Compound heterozygosity: affected individuals may carry two different pathogenic variants rather than the same variant twice. Molecular testing must be interpreted accordingly.
- Genetic heterogeneity: apparently similar phenotypes may be caused by mutations in different genes (Usher syndrome, autosomal recessive deafness, and congenital disorders of glycosylation are notable examples).
- Reduced penetrance in AR conditions: less common than for dominants but occurs (hereditary haemochromatosis being a widely discussed example).
- Carrier screening sensitivity: a negative panel test reduces but does not eliminate carrier probability. Residual risk depends on panel coverage for the patient's ancestry.
How Evagene supports this
Evagene's Mendelian inheritance calculator evaluates autosomal recessive transmission on the pedigree, using ICD-10 and OMIM-coded disease annotation across the 200+ catalogued conditions. When a condition annotated on the pedigree is consistent with AR inheritance, the calculator applies the 25/50/25 carrier-by-carrier rule and propagates carrier and affected probabilities through the pedigree. Unaffected siblings of an affected proband are assigned the 2/3 posterior carrier probability automatically.
Evagene's automatic consanguinity detection flags related parents on the pedigree and calculates Wright's coefficient of relationship and inbreeding coefficient F. The recessive-risk calculation incorporates F, so offspring of consanguineous couples receive a correctly amplified risk estimate without requiring manual adjustment. For ancestry-stratified conditions, ancestry auto-calculation from 23andMe imports or manual entry allows the calculator to select an appropriate population carrier frequency.
Batch risk screening applies this analysis across the full disease catalogue for a given proband, surfacing recessive conditions where family history or consanguinity crosses a counselling threshold — a useful backstop when a clinician might not otherwise have suspected a particular condition.
Frequently asked questions
What is the risk when both parents are carriers?
1/4 affected, 2/4 carrier, 1/4 non-carrier per pregnancy, independently.
What is an unaffected sibling's carrier probability?
2/3, after excluding the affected outcome through Bayesian conditioning.
How does consanguinity affect recessive risk?
It raises the probability that both parents carry the same ancestral allele. For rare alleles the effect is dominated by the inbreeding coefficient F multiplied by the allele frequency.
What is pseudodominance?
An AR condition that looks autosomal dominant because an affected homozygote partners a carrier. Pattern, not mechanism.
Where do carrier frequencies come from?
Population data and Hardy-Weinberg estimation. Frequencies are population-specific; use the patient's relevant ancestry.
Does Evagene support recessive calculations?
Yes, with automatic consanguinity detection and Wright's coefficient integration.